SCHEMBL28845264

SCHEMBL28845264

Cc1c(Cl)cccc1-c1ccnc(Cl)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.49
KMO O15229 1/20 0.42
DYRK1A Q13627 2/20 0.38
PIK3CA P42336 2/20 0.37
PIK3CB P42338 2/20 0.37
PIK3CG P48736 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NR4A2 P43354 1/20 0.35
GAA P10253 1/20 0.35
MAPK14 Q16539 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ABL1 P00519 1/20 0.34
CYP19A1 P11511 1/20 0.33
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL447060 0.82 CYP19A1 (0.47) IDO1KMODYRK1AALDH1A1L3MBTL1
SCHEMBL3396168 0.80 KMO (0.35) IDO1KMODYRK1APIK3CAPIK3CB
SCHEMBL38658216 0.79 DYRK1A (0.35) DYRK1APIK3CAPIK3CBPIK3CGCYP3A4
SCHEMBL2353608 0.79 CYP1A2 (0.44) IDO1DYRK1AALDH1A1L3MBTL1GAA
SCHEMBL4001966 0.77 TDP1 (0.49) ALDH1A1GAA
SCHEMBL17453624 0.77 ALDH1A1 (0.41) KMODYRK1APIK3CAPIK3CBPIK3CG
SCHEMBL28101879 0.76 IDO1 (0.49) IDO1ALDH1A1CNR2L3MBTL1MAPK14
SCHEMBL1469707 0.75 KMO (0.33) KMOALDH1A1
SCHEMBL11064947 0.75 IDO1 (0.51) IDO1ALDH1A1L3MBTL1GAAMAPK14
SCHEMBL5786593 0.74 MAPT (0.43) DYRK1AALDH1A1GAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 CN disclosed